BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38151223)

  • 1. One-day versus two-day mifepristone-misoprostol interval prior to initiation of misoprostol during late second trimester medication abortion: A cohort study.
    Sium AF; Teklu H; Reeves M; Tolu LB; Prager S
    Contraception; 2024 Apr; 132():110356. PubMed ID: 38151223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of induced fetal demise on induction to expulsion interval during later medication abortion: A retrospective cohort.
    Sium AF; Shimeles T; Gudu W
    Contraception; 2023 Sep; 125():110092. PubMed ID: 37331459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mifepristone-Misoprostol Use for Second- and Third-Trimester Medical Termination of Pregnancy in a Canadian Tertiary Care Centre.
    Vlad S; Boucoiran I; St-Pierre ÉR; Ferreira E
    J Obstet Gynaecol Can; 2022 Jun; 44(6):683-689. PubMed ID: 35114381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Same-day mifepristone prior to second-trimester induction termination with misoprostol: A retrospective cohort study.
    Shay RL; Benson LS; Lokken EM; Micks EA
    Contraception; 2022 Mar; 107():29-35. PubMed ID: 34529952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone-misoprostol dosing interval and effect on induction abortion times: a systematic review.
    Shaw KA; Topp NJ; Shaw JG; Blumenthal PD
    Obstet Gynecol; 2013 Jun; 121(6):1335-1347. PubMed ID: 23812471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of shorter mifepristone to misoprostol intervals for second trimester medical abortion: a retrospective cohort study.
    Henkel A; Lerma K; Blumenthal PD; Shaw KA
    Contraception; 2020 Nov; 102(5):327-331. PubMed ID: 32592800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of induction-to-expulsion interval during second-trimester medication abortion in pregnancies with anencephaly and other congenital anomalies compared to those without anomalies: A retrospective cohort study.
    Hailu D; Teklu H; Sium AF
    Contraception; 2024 Feb; 130():110339. PubMed ID: 37992851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One- and two-day mifepristone-misoprostol intervals for second trimester termination of pregnancy between 13 and 16 weeks of gestation.
    Hou S; Zhang L; Chen Q; Fang A; Cheng L
    Int J Gynaecol Obstet; 2010 Nov; 111(2):126-30. PubMed ID: 20705290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcomes and Women's Experiences before and after the Introduction of Mifepristone into Second-Trimester Medical Abortion Services in South Africa.
    Constant D; Harries J; Malaba T; Myer L; Patel M; Petro G; Grossman D
    PLoS One; 2016; 11(9):e0161843. PubMed ID: 27583448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous Administration Compared With a 24-Hour Mifepristone-Misoprostol Interval in Second-Trimester Abortion: A Randomized Controlled Trial.
    Abbas DF; Blum J; Ngoc NT; Nga NT; Chi HT; Martin R; Winikoff B
    Obstet Gynecol; 2016 Nov; 128(5):1077-1083. PubMed ID: 27741182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mifepristone-misoprostol versus misoprostol-alone regimen for medication abortion at ≥24 weeks' gestation.
    Wingo E; Raifman S; Landau C; Sella S; Grossman D
    Contraception; 2020 Aug; 102(2):99-103. PubMed ID: 32407810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
    Mentula M; Suhonen S; Heikinheimo O
    Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The abortifacient effect of misoprostol in the second trimester. A randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486).
    el-Refaey H; Hinshaw K; Templeton A
    Hum Reprod; 1993 Oct; 8(10):1744-6. PubMed ID: 8300840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One or two day mifepristone-misoprostol interval for second trimester abortion.
    Nilas L; Glavind-Kristensen M; Vejborg T; Knudsen UB
    Acta Obstet Gynecol Scand; 2007; 86(9):1117-21. PubMed ID: 17712654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy and safety of mifepristone combined with misoprostol for termination of pregnancy between 8 and 16 weeks of gestation].
    Qian J; Jing X; Wu S; Zheng S; Li Y; Ren M; Di W; Shen H; Dong B; Chang Q; Shi H; Yao C; Song W; Huang Z
    Zhonghua Fu Chan Ke Za Zhi; 2015 Jul; 50(7):505-9. PubMed ID: 26311640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 24-Hour Compared With 12-Hour Mifepristone-Misoprostol Interval for Second-Trimester Abortion: A Randomized Controlled Trial.
    Meyer R; Toussia-Cohen S; Shats M; Segal O; Mohr-Sasson A; Peretz-Bookstein S; Amitai-Komem D; Sindel O; Levin G; Mashiach R; Blumenthal PD
    Obstet Gynecol; 2024 May; ():. PubMed ID: 38781593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misoprostol is as effective as gemeprost in termination of second trimester pregnancy when combined with mifepristone: a randomised comparative trial.
    Ho PC; Chan YF; Lau W
    Contraception; 1996 May; 53(5):281-3. PubMed ID: 8724617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mifepristone and Misoprostol vs Misoprostol Alone in Second Trimester Termination of Pregnancy.
    Shah D; Rijal P; Thakur A; Rai R
    JNMA J Nepal Med Assoc; 2018; 56(213):856-860. PubMed ID: 31065120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy.
    Bartley J; Baird DT
    BJOG; 2002 Nov; 109(11):1290-4. PubMed ID: 12452468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.